Metastron

   
Google
 
Web NewDrugInformation.com

Metastron


Drug - Metastron
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Strontium Chloride, Sr-89
Multiple ingredients are in alphabetical order.

Strength - 1mCi/ML
The potency of the active ingredient(s), Strontium Chloride, Sr-89. May repeat for multiple part products.

Applicant - GE HEALTHCARE
The firm name holding legal responsibility for Metastron. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020134
The FDA assigned number to Metastron. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Metastron. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 18, 1993
The date Metastron was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Metastron. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Metastron is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ge Healthcare
The full name of the firm holding legal responsibility for the new application of Metastron.

Metastron